Clinical trial
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate…
NCT00383487 · Stanford University, Other · Terminated
Key facts
| NCT number | NCT00383487 |
|---|---|
| Title | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer |
| Official title | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer |
| Lead sponsor | Stanford University, Other |
| Collaborators | Novacea Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostatic Neoplasms, Prostate Cancer |
| Intervention type | Drug |
| Interventions | Calcitriol, Naproxen-n-butyl nitrate |
| Enrollment | 20 |
| Start date | Mar 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Oct 3, 2006 |
| Last update posted | Jan 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: